Advertisement
COCP vs SRPT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a Hold and SRPT is a Hold.
Momentum Indicator for COCP turns positive, indicating new upward trend
COCP saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 81 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where COCP's RSI Indicator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for COCP just turned positive on October 30, 2026. Looking at past instances where COCP's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
Following a +9.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where COCP advanced for three days, in 165 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 45 cases where COCP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
COCP moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for COCP crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
The 50-day moving average for COCP moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COCP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
COCP broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for COCP entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. COCP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.189) is normal, around the industry mean (3.498). P/E Ratio (-1.387) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (45.249) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
SRPT in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 10, 2026
SRPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 40 cases where SRPT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for SRPT moved above the 200-day moving average on October 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRPT advanced for three days, in 223 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRPT as a result. In 63 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for SRPT turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
SRPT moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for SRPT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.232) is normal, around the industry mean (3.498). P/E Ratio (-12.205) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (1.125) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. SRPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
COCP | SRPT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 93 | |
PRICE GROWTH RATING 1..100 | 69 | 70 | |
P/E GROWTH RATING 1..100 | 60 | 98 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SRPT's Valuation (12) in the Biotechnology industry is significantly better than the same rating for COCP (86) in the Pharmaceuticals Generic industry. This means that SRPT’s stock grew significantly faster than COCP’s over the last 12 months.
SRPT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that SRPT’s stock grew similarly to COCP’s over the last 12 months.
SRPT's SMR Rating (93) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that SRPT’s stock grew similarly to COCP’s over the last 12 months.
COCP's Price Growth Rating (69) in the Pharmaceuticals Generic industry is in the same range as SRPT (70) in the Biotechnology industry. This means that COCP’s stock grew similarly to SRPT’s over the last 12 months.
COCP's P/E Growth Rating (60) in the Pharmaceuticals Generic industry is somewhat better than the same rating for SRPT (98) in the Biotechnology industry. This means that COCP’s stock grew somewhat faster than SRPT’s over the last 12 months.
| COCP | SRPT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | N/A |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 76% |
| Advances ODDS (%) | 3 days ago 83% | 8 days ago 77% |
| Declines ODDS (%) | 1 day ago 84% | 2 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COCP’s FA Score shows that 0 FA rating(s) are green while SRPT’s FA Score has 1 green FA rating(s).
- COCP’s FA Score: 0 green, 5 red.
- SRPT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COCP’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).
- COCP’s TA Score: 4 bullish, 7 bearish.
- SRPT’s TA Score: 4 bullish, 5 bearish.
Price Growth
COCP (@Biotechnology) experienced а +0.99% price change this week, while SRPT (@Biotechnology) price change was -12.16% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
Reported Earning Dates
COCP is expected to report earnings on Nov 13, 2026.
SRPT is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Biotechnology (-0.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
COCP and
Correlation & Price change
A.I.dvisor tells us that COCP and SRPT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCP and SRPT's prices will move in lockstep.
| Ticker / NAME | Correlation To COCP | 1D Price Change % | ||
|---|---|---|---|---|
| COCP | 100% | -0.97% | ||
| SRPT - COCP | 30% Poorly correlated | +1.58% | ||
| BYSI - COCP | 28% Poorly correlated | +11.06% | ||
| CYTK - COCP | 27% Poorly correlated | +4.18% | ||
| CMMB - COCP | 27% Poorly correlated | +0.37% | ||
| MBIO - COCP | 27% Poorly correlated | -3.06% | ||
More | ||||
SRPT and
Correlation & Price change
A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then RCKT could also see price increases.
| Ticker / NAME | Correlation To SRPT | 1D Price Change % | ||
|---|---|---|---|---|
| SRPT | 100% | +1.58% | ||
| RCKT - SRPT | 51% Loosely correlated | +1.22% | ||
| DNLI - SRPT | 49% Loosely correlated | -0.60% | ||
| SANA - SRPT | 48% Loosely correlated | -5.76% | ||
| DYN - SRPT | 48% Loosely correlated | +0.39% | ||
| LXEO - SRPT | 45% Loosely correlated | +0.33% | ||
More | ||||